key: cord-0018181-i4a0c2tj authors: Laillou, Arnaud; Baye, Kaleab; Zelalem, Meseret; Chitekwe, Stanley title: Vitamin A supplementation and estimated number of averted child deaths in Ethiopia: 15 years in practice (2005–2019) date: 2020-12-17 journal: Matern Child Nutr DOI: 10.1111/mcn.13132 sha: 867d3d5653317c3d4365bdd9a5947f75fa47ccd0 doc_id: 18181 cord_uid: i4a0c2tj Vitamin A supplementation (VAS), started as a short‐term strategy pending dietary improvements, has been implemented in Ethiopia for the last 15 years. We aimed to describe the trends in VAS coverage and estimated the associated reductions in child mortality. VAS coverage data obtained from the District Health Information System and the Demographic and Health Surveys were linked to child mortality data from the United Nations Interagency Group for Child Mortality Estimation (UN IGME). The number of child deaths averted was modelled assuming 12% and 24% reductions in all‐cause mortality. From 2006 to 2011, VAS was delivered through campaigns, and coverage was above 85%. However, from 2011 onwards, VAS delivery was integrated to the routine health system, and the coverage declined to <60% with significant disparities by wealth quintile and rural–urban residence. VAS has saved between 167,563 to 376,030 child lives (2005–2019), but additional lives (>42,000) could have been saved with a universal coverage (95%). Inconsistent supply of vitamin A capsules, but more importantly, low access to health care, and the limited contact opportunities for children after 24 months may have contributed to the declining VAS coverage. Any changes in target or scale‐up should thus consider these spatial and socioeconomic variations. Increasing the coverage of VAS and closing the equity gap in access to nutrition services is critical. However, with alternative programmes like vitamin A fortification being set‐up, the benefits and safety of VAS need to be closely monitored, particularly in areas where there will be overlap. Vitamin A deficiency (VAD) is believed to be one of the most widespread nutrient deficiency in low-and middle-income countries (LMIC; World Health Organization, 2009) . Despite limited number of national surveys that estimate the magnitude of vitamin A deficiency, the low dietary diversity, often characterized by limited consumption of vitamin A-rich fruits, vegetables and animal source foods, is likely to contribute to VAD in LMIC (de Pee, West, Hautvast, Muhilal, & West, 1995) . Besides, both acute and chronic inflammation/infection has been linked to increased utilization and excretion of vitamin A, further contributing to the aetiology of VAD (World Health Organization, 2009), whereas increased vitamin A intake is in-turn linked to reduced morbidity and mortality from infectious diseases (Beaton et al., 1993; Stevens et al., 2015) . Fund, 2000 Fund, , 2005 Fund, , 2011 Fund, , 2016 . Albendazole is almost always provided along with vitamin A supplements for children aged 24-59 months. Therefore, the coverage of albendazole was used to validate the accuracy of VAS coverage. The DHS surveys are nationally representative and collect information on household demographic and socioeconomic characteristics and on vitamin A supplementation over the last 6 months. The surveys were based on stratified samples selected at two stages, and each reporting domain was disaggregated by rural-urban residence. The health monitoring data collected by the health worker was obtained from the Health Monitoring Information system (HMIS), and since 2016, this was obtained from the District Health Information System (DHIS2) of the Ethiopian Federal Ministry of Health. The yearly coverage of VAS and albendazole (number of capsules administrated to the targeted population by the health worker) was obtained from the DHIS2 (see Data S1). The proportion of children that has taken one or two dose of vitamin A or albendazole supplementation was calculated. Child mortality data were taken from the United Nations Interagency Group for Mortality Estimation (2020). We calculated the mortality rate and the number of child deaths in the presence and absence of VAS. The number of deaths that would have been averted, if near universal coverage of 95% was achieved, was calculated. The model linked the VAS coverage to reductions in mortality using the following equation: • Over the last 14 years (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) (2018) , at least three quarters of the targeted population received at least one dose of vitamin A. • Inequalities in VAS coverage persist due to low access to health care. • VAS programme has contributed to substantial reductions in child death in Ethiopia, despite a declining coverage; 167,563 to 376,030 child lives were saved between 2005 and 2019. • The high rates of VAS-sensitive mortalities support the scale-up of VAS. Coverage change × effectiveness × affected proportion = Impact More details about the basic calculations are presented in Tables S1 and S2. The model assumed two scenarios using VASrelated mortality reductions of 24%, based on the meta-analysis of Mayo-Wilson, Imdad, Herzer, Yakoob and Bhutta (2011) or a much lower mortality reductions of 12% as argued by Mason, Greiner, Shrimpton, Sanders and Yukich (2015) and Raiten et al. (2020) . In a Cochrane Systematic Review published by Imdad, Mayo-Wilson, Herzer and Bhutta (2017), a 24% reduction in all-cause mortality was reported. The addition of the Deworming and Enhanced Vitamin A Supplementation Trial was argued to cut by half (12%) the reduction in all-cause mortality. In light of this heterogeneity, and the true value expected to be anywhere between 12% and 24%, we have used these two scenarios to estimate the mortality reductions. The distribution of VAS was first started in 2004 in four drought prone regions and by 2006 has become a national strategy delivered through biannual campaigns: (i) enhanced outreach services (EOS) 1 and (ii) Child Health Days (CHDs) 2 (Table 1 ). The implementation of the VAS programme has evolved over the years. The programmes implemented in EOS were transitioned to delivery through CHDs, and later was gradually integrated with the routine health services. Routinely, every child aged 6-59 months would receive, twice a year, vitamin A supplement during contacts at the health post. The annual VAS coverages of at least one or two capsules per year are presented in Figures 1 and 2 , respectively. Over the 15 years of implementation, coverage rates of children receiving at least two capsules of vitamin ranged from 41% to 93% (Figures S1 and S2). During the first years of the initiative (2006-2011), the VAS coverage was above 85% but has since declined to reach coverage levels <70% for one dose and <60% for two doses of VAS per year (Figures S1 and S2). However, over the last 14 years (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) (2018) , at least 75% of the targeted population received at least one dose of vitamin A. Similar trends than VAS were observed for the coverage of albendazole ( Figure 1 ). (Figures 3 and 4) . Depending on the assumed reduction in mortality, the national VAS programme could have saved an additional 42,571 to 106,299 child death in Ethiopia if the VAS coverage reached 95% (Figure 4) . We have estimated that if the coverage continues to stay around 50% in 2020/2021 or even decrease to 30%, the programme will miss the opportunity to avert an estimated 5592 to 20,422 child death over the next 2 years. Year Topic The enhanced outreach strategy started in four drought prone region. F I G U R E 3 Estimated mortality rates in the presence and absence of preventive vitamin A supplementation among children aged 6-59 months (assuming a 12% or 24% mortality due to vitamin A), 2005 to 2019 operational since the 1990s and has expanded to more than 80 countries (Latham, 2010) . In Ethiopia, the programme was started in the but several nutrition services can be scaled-up to maximize impact on child health and well-being (Baye, 2019) . Indeed, from the analyses of the demographic and health survey, Haile, Biadgilign and Azage (2015) showed that children from poorer households were less likely to receive VAS. This is unfortunate, because the poor and the most remote are also those who have the lowest composite coverage index, reflecting low coverage of essential reproductive, maternal, neonatal and child health interventions (Baye, Laillou, & Chitweke, 2020 (Hay, 2019) . Studying the local variation in childhood diarrhoeal morbidity and mortality in Africa, Reiner et al. (2018) reported that the burden of diarrheal incidence is concentrated within parts of Ethiopia, with the Southern Nations, Nationalities, and Peoples' region (SNNPR), Oromia and Amhara contributing a significant share to the burden of severe cases of diarrhoea in Africa. Immunization coverage in Ethiopia, including measles, is also significantly lower (<60%) than the global target (Tamirat & Sisay, 2019 (Harika et al., 2017) , assessing the potential Prioritizing the scale-up of evidence-based nutrition and health interventions to accelerate stunting reduction in Ethiopia Socio-economic inequalities in child stunting reduction in sub-Saharan Africa Effectiveness of vitamin A supplementation in the control of young child morbidity and mortality in developing countries An enigma: Why vitamin A supplementation does not always reduce mortality even though vitamin A deficiency is associated with increased mortality Premature abandonment of global vitamin A supplementation programmes is not prudent! Lack of improvement in vitamin A status with increased consumption of dark-green leafy vege-tables Magnitude and distribution of vitamin A deficiency in Ethiopia Ethiopia mini demographic and health survey 2000: Key indicators Ethiopia mini demographic and health survey 2005: Key indicators Ethiopia mini demographic and health survey 2011: Key indicators Ethiopia mini demographic and health survey 2016: Key indicators Delivering vitamin A supplements to children aged 6 to 59 months: Comparing delivery through mass campaign and through routine health services in Ethiopia Does India need a universal high-dose vitamin A supplementation program? Neonatal vitamin A supplementation: Time to move on Differentials in vitamin A supplementation among preschool-aged children in Ethiopia: Evidence from the 2011 Ethiopian Demographic and Health Survey Micronutrient status and dietary intake of iron, vitamin A, iodine, folate and zinc in women of reproductive age and pregnant women in Ethiopia, Kenya, Nigeria and South Africa: A systematic review of data from Maintaining progress for the most beautiful chart in the world Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age The great vitamin A fiasco Vitamin A policies need rethinking Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: Systematic review and meta-analysis The role of health extension workers in improving utilization of maternal health services in rural areas in Ethiopia: A cross sectional study Perspective: Integration to implementation (I-to-I) and the micronutrient forum-Addressing the safety and effectiveness of vitamin A supplementation Variation in childhood diarrheal morbidity and mortality in Africa Prevalence of vitamin A deficiency among preschool children in Ethiopia: A systematic review and meta-analysis Trends and mortality effects of vitamin A deficiency in children in 138 low-income and middle-income countries between 1991 and 2013: A pooled analysis of population-based surveys Full immunization coverage and its associated factors among children aged 12-23 months in Ethiopia: Further analysis from the 2016 Ethiopia demographic and health survey Coverage at a crossroads: New directions for vitamin a supplementation programmes Under-5, infant mortality rate, number of infant deaths and number of under-5 deaths Early neonatal vitamin A supplementation and infant mortality: An individual participant data meta-analysis of randomised controlled trials Vitamin A supplementation programs and country-level evidence of vitamin A deficiency Global prevalence of vitamin a deficiency in populations at risk Guideline: Vitamin A supplementation in infants and children 6-59 months of age Immunization service delivery and accelerated disease control. vitamin A; opportunities to link vitamin A supplementation with immunization Vitamin A supplementation and estimated number of averted child deaths in Ethiopia: 15 years in practice